POAI

POAI

USD

Predictive Oncology Inc. Common Stock

$1.060-0.040 (-3.636%)

Echtzeitkurs

Healthcare
Medical Instruments & Supplies
Vereinigte Staaten

Kursdiagramm

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.100

Hoch

$1.125

Tief

$1.000

Volumen

0.00M

Unternehmensfundamentaldaten

Marktkapitalisierung

9.7M

Branche

Medical Instruments & Supplies

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

2.88M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.55Aktuell $1.060Hoch $3.06

KI-Analysebericht

Zuletzt aktualisiert: 26. Apr. 2025
KI-generiertDatenquelle: Yahoo Finance, Bloomberg, SEC

POAI (Predictive Oncology Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: POAI Generate Date: 2025-04-26 20:44:53

Let's break down what's been going on with Predictive Oncology lately, looking at the news, how the stock price has moved, and what some of the data suggests might happen.

What's Been Happening? (News & Price Check)

First off, the recent news flow for Predictive Oncology seems to carry a generally positive tone. We saw an update about their agreement with Renovaro Biosciences, which sounds like progress on a potential collaboration or deal. Then there was the year-end financial report – the title itself is standard, but paired with other news, it fits into a picture of the company providing updates. Crucially, they announced selling off their Skyline Medical assets. This move is specifically framed as letting the company sharpen its focus squarely on its core AI-driven drug discovery work. Getting rid of non-core stuff to concentrate on the main game is often seen as a good strategic step.

Now, looking at the stock price chart over the last few months... wow, it's been a wild ride. For a while, the price was bumping around between roughly $1.00 and $1.50. But then came a massive spike in late March, pushing the price way up on huge trading volume. After that big jump, the stock pulled back sharply through early April, dropping down below the $1.00 mark. More recently, over the last week or so, it looks like the price might be trying to find its footing or bounce a little from those lower levels, closing around $1.06 most recently.

The AI prediction for the very near term (today and the next couple of days) suggests things might be relatively quiet right after this recent bounce – maybe a tiny dip today, then small gains. It doesn't point to another huge move immediately in either direction.

What It Might Mean (Outlook & Ideas)

Putting the pieces together – positive news about focusing the business and potential deals, a stock price that saw a massive spike and crash but is now trying to bounce from recent lows, and an AI predicting near-term calm – what does it suggest?

The situation looks pretty mixed, but with some potentially positive signs trying to emerge after a period of sharp decline. The news about focusing on AI is a clear strategic positive. The price action shows extreme volatility is possible here, but the recent bounce from the lows could indicate some buyers are stepping in at these levels.

Given the recent bounce and the positive strategic news, the current situation might lean slightly towards a potential stabilization or even a cautious 'hold' or 'accumulate' view for those comfortable with high risk. However, the massive volatility we just saw cannot be ignored.

If someone were considering this stock based on the recent bounce and strategic news, a potential entry point could be considered around the current price level (around $1.06) or perhaps on a slight dip if the AI's prediction of a small drop today plays out. This area aligns with where the stock seems to have found some support recently and matches some potential entry levels mentioned in other data points.

Thinking about managing risk, if the price were to fall back significantly below the recent lows (say, below $0.92, which is a level suggested in some data as a potential stop-loss), that might be a signal that the recent bounce isn't holding and the downtrend could continue. On the flip side, if the stock continues to recover, a potential level to watch for taking some profits might be around $1.18, which is above the recent bounce high and could act as resistance.

Quick Company Snapshot

Just to remember, Predictive Oncology is primarily an AI company focused on cancer drug discovery. Selling off that medical fluid business (Skyline Medical) makes sense in that context – they're doubling down on the AI side. Keep in mind this is a relatively small company (small market cap) and, as the chart clearly shows, its stock can be incredibly volatile. The trading volume can be quite low on quiet days, but explodes when there's big news or price moves.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing is risky, and prices can go down as well as up. You should always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Ähnliche Nachrichten

GlobeNewswire

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ:RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today

Mehr anzeigen
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
GlobeNewswire

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

PITTSBURGH, April 01, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository

Mehr anzeigen
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
GlobeNewswire

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and

Mehr anzeigen
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

KI-VorhersageBeta

KI-Empfehlung

Bärisch

Aktualisiert am: 28. Apr. 2025, 12:32

BärischNeutralBullisch

55.1% Konfidenz

Risiko & Handel

Risikostufe3/5
Mittleres Risiko
Geeignet für
WertWachstumAggressiv
Handelsleitfaden

Einstiegspunkt

$1.02

Gewinnmitnahme

$1.19

Stop-Loss

$0.92

Schlüsselfaktoren

DMI zeigt bärischen Trend (ADX:18.2, +DI:26.4, -DI:32.0), was zur Vorsicht mahnt
MACD -0.0113 liegt über der Signallinie -0.0118, was auf einen bullischen Crossover hindeutet

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.